Insight Molecular Diagnostics Inc.

Nasdaq:IMDX

In Vitro & In Vivo Diagnostic Substances·NASHVILLE, TN

Insight is the understanding of a specific cause and effect within a particular context.

CEO

Riggs Josh

CFO

James Andrea S.

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/10/25	→
10-Q	Q2 2025	6/30/25	8/11/25	→
10-Q	Q1 2025	3/31/25	5/12/25	→
10-K	FY 2024	12/31/24	3/24/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
10-Q	Q2 2024	6/30/24	8/8/24	→
↓

Earnings Releases (8-K)

19 shown

Filed	Period
11/10/25	Q4 FY2025	→
8/11/25	Q3 FY2025	→
5/12/25	Q2 FY2025	→
3/24/25	Q1 FY2025	→
11/12/24	Q4 FY2024	→
8/8/24	Q3 FY2024	→
↓

News (8-K)

61 shown

Filed	Type	Description
2/26/26	Agreement	Entry into a Material Definitive Agreement	→
2/12/26	Agreement	Entry into a Material Definitive Agreement	→
2/11/26	Reg FD	Regulation FD Disclosure	→
10/2/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
9/19/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
7/2/25	Vote	Submission of Matters to a Vote of Security Holders	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
2/11/26	424B5	424B5	→
8/18/25	S-8	S-8	→
5/14/25	ARS	ARS	→
4/8/25	424B3	424B3	→
3/28/25	S-1	S-1	→
2/10/25	424B5	424B5	→
↓

Filing History(662 filings)

TypeDateAccessionPeriodSize

8-K

Feb 26, 2026

0001493152-26-0081698-K

Feb 20, 2026

197.6 KB

SCHEDULE 13D/A

Feb 12, 2026

0000919574-26-000780

—

22.3 KB

Feb 12, 2026

0000919574-26-000779

Feb 10, 2026

14.7 KB

8-K

Feb 12, 2026

0001493152-26-0064738-K

Feb 10, 2026

688.9 KB

424B5

Feb 11, 2026

0001493152-26-006218424B5

—

398.0 KB

8-K

Feb 11, 2026

0001493152-26-0061178-K

Feb 11, 2026

18.6 MB

4/A

Nov 13, 2025

0001493152-25-022358

Oct 31, 2025

9.8 KB

10-Q

Nov 10, 2025

0001193125-25-27426610-Q

Sep 30, 2025

14.4 MB

8-K

Nov 10, 2025

0001493152-25-0215138-K

Nov 10, 2025

3.1 MB

Nov 4, 2025

0001493152-25-0207194

Oct 31, 2025

7.9 KB

8-K

Oct 2, 2025

0001493152-25-0166858-K

Sep 28, 2025

219.9 KB

Sep 30, 2025

0001493152-25-0163604

Sep 28, 2025

5.7 KB

Sep 30, 2025

0001493152-25-0163494

Sep 28, 2025

5.7 KB

Sep 30, 2025

0001493152-25-0162914

Sep 28, 2025

5.7 KB

8-K

Sep 19, 2025

0001493152-25-0142408-K

Sep 16, 2025

193.4 KB

S-8

Aug 18, 2025

0001641172-25-024607S-8

—

311.9 KB

10-Q

Aug 11, 2025

0000950170-25-10655210-Q

Jun 30, 2025

14.0 MB

8-K

Aug 11, 2025

0001641172-25-0229748-K

Aug 11, 2025

686.0 KB

Jul 3, 2025

0001641172-25-017796

Jul 1, 2025

4.9 KB

Jul 3, 2025

0001641172-25-017798

Jul 1, 2025

7.1 KB

Jul 3, 2025

0001641172-25-017787

Jul 1, 2025

5.0 KB

8-K

Jul 2, 2025

0001641172-25-0175908-K

Jun 27, 2025

215.0 KB

8-K

Jun 17, 2025

0001641172-25-0153388-K

Jun 13, 2025

495.3 KB

ARS

May 14, 2025

0001641172-25-010398

Dec 31, 2024

1.7 MB

DEFA14A

May 14, 2025

0001641172-25-010369DEFA14A

—

1.0 MB

25 filings shown

Insight Molecular Diagnostics Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(662 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/12/26	4	4	→
11/13/25	4/A	4/A	→
11/4/25	4	4	→
9/30/25	4	4	→
9/30/25	4	4	→
9/30/25	4	4	→
↓

Filed	Form	Description
5/14/25	DEFA14A	DEFA14A	→
5/14/25	DEF 14A	DEF 14A	→
9/25/24	DEF 14A	DEF 14A	→
4/29/24	DEF 14A	DEF 14A	→
7/21/23	DEFA14A	DEFA14A	→
7/10/23	DEF 14A	DEF 14A	→
↓